PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 217 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,987,657 | -15.0% | 245,578 | +1.2% | 1.22% | -18.8% |
| Q1 2023 | $11,753,433 | +68.6% | 242,639 | +32.8% | 1.50% | +60.8% |
| Q4 2022 | $6,972,361 | -63.5% | 182,666 | -51.9% | 0.93% | -63.6% |
| Q3 2022 | $19,080,000 | +0.9% | 380,089 | -19.5% | 2.56% | +22.1% |
| Q2 2022 | $18,907,000 | +42.5% | 471,978 | +32.7% | 2.10% | +67.2% |
| Q1 2022 | $13,270,000 | -6.3% | 355,661 | +0.0% | 1.26% | +12.4% |
| Q4 2021 | $14,166,000 | +6.3% | 355,660 | -0.7% | 1.12% | +0.4% |
| Q3 2021 | $13,328,000 | -17.5% | 358,193 | -6.2% | 1.11% | -14.5% |
| Q2 2021 | $16,149,000 | -11.4% | 382,038 | -0.8% | 1.30% | -18.7% |
| Q1 2021 | $18,230,000 | -18.1% | 385,014 | +5.5% | 1.60% | -15.5% |
| Q4 2020 | $22,266,000 | +111.4% | 364,837 | +61.9% | 1.90% | +113.4% |
| Q3 2020 | $10,535,000 | -12.7% | 225,355 | -5.3% | 0.89% | -16.8% |
| Q2 2020 | $12,069,000 | +40.2% | 237,865 | +23.3% | 1.07% | +5.0% |
| Q1 2020 | $8,608,000 | – | 192,953 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |